Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Lindsay Morton

Childhood cancer survivor study (CCSS)

Sarcoma Thyroid Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Melanoma of skin Lip, oral cavity Leukaemia Larynx Kidney, renal pelvis and ureter Hodgkin lymphoma Breast Brain, nervous system

Radiation Oncology Pediatric oncology or childhood cancer

Ralph D Sanderson

Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Differentiation of Granulocytes and Macrophages

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Daniel M Sullivan

CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS

Multiple myeloma and immunoproliferative diseases

Timothy A Springer

Integrin-Targeted siRNA Delivery for Therapeutic Gene Silencing in Blood Cancers

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Kenneth C. Anderson

SPORE in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Kelvin P. Lee

CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival

Multiple myeloma and immunoproliferative diseases

Qing Lan

A Hospital-based Case-control Study of Lymphoma in Asia (AsiaLymph)

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies